Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;74(5):2903.
doi: 10.1002/hep.31632.

Letter to the Editor: More Efforts for Detecting the Elevated Liver Biochemistries in Patients With Severe COVID-19

Yi-Ming Lin  1 , Ai-Yong Cui  1 , Da-Wei Wang  1 , Hua-Ding Lu  1
Affiliations
Comment

Letter to the Editor: More Efforts for Detecting the Elevated Liver Biochemistries in Patients With Severe COVID-19

Yi-Ming Lin et al. Hepatology. 2021 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK. Elevated liver biochemistries in hospitalized Chinese patients with severe COVID‐19: Systematic review and meta‐analysis. Hepatology 2020. 10.1002/hep.31472. [Epub ahead of print] - DOI - PMC - PubMed
    1. McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta‐analyses? Lancet 2000;356:1228‐1231. - PubMed
    1. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002. 10.1136/bmj.d4002. - DOI - PubMed
    1. Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, et al. Impact of chronic liver disease on outcomes of hospitalized patients with COVID‐19: A multicentre United States experience. Liver Int 2020;40:2515‐2521. 10.1111/liv.14583. - DOI - PMC - PubMed

Substances